CN Patent

CN106279331B — 胆酸类肝病治疗药物

Assigned to Individual · Expires 2019-06-14 · 7y expired

What this patent protects

本发明涉及一种胆甾烷类化合物，由3α‑羟基‑7‑氧代‑5β‑胆甾烷‑24‑酸甲酯为原料进行合成，此制备方法简便易行、收率高，质量好，便于工业化生产。本发明的胆甾烷类化合物用于制备治疗或预防非酒精性脂肪肝、原发性胆汁性肝硬化的组合物。

USPTO Abstract

本发明涉及一种胆甾烷类化合物，由3α‑羟基‑7‑氧代‑5β‑胆甾烷‑24‑酸甲酯为原料进行合成，此制备方法简便易行、收率高，质量好，便于工业化生产。本发明的胆甾烷类化合物用于制备治疗或预防非酒精性脂肪肝、原发性胆汁性肝硬化的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN106279331B
Jurisdiction
CN
Classification
—
Expires
2019-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.